216 related articles for article (PubMed ID: 21864265)
1. B cell modulation strategies in autoimmunity: the SLE example.
Rosado MM; Diamanti AP; Capolunghi F; Carsetti R
Curr Pharm Des; 2011; 17(29):3155-65. PubMed ID: 21864265
[TBL] [Abstract][Full Text] [Related]
2. B cells in SLE: different biological drugs for different pathogenic mechanisms.
Diamanti AP; Rosado MM; Carsetti R; Valesini G
Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
[TBL] [Abstract][Full Text] [Related]
3. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
Murphy G; Lisnevskaia L; Isenberg D
Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
[TBL] [Abstract][Full Text] [Related]
5. B cell biology: implications for treatment of systemic lupus erythematosus.
Anolik JH
Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
7. Cellular targeting in autoimmunity.
Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
[TBL] [Abstract][Full Text] [Related]
8. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
Tanaka Y
Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
Sthoeger Z; Sharabi A; Mozes E
J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
[TBL] [Abstract][Full Text] [Related]
10. [BCMA and autoantibody-producing RP105 B cells; possible new targets of B cell therapy in systemic lupus erythematosus].
Koarada S; Tashiro S; Suematsu R; Inoue H; Ohta A; Tada Y
Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(1):38-45. PubMed ID: 22374441
[TBL] [Abstract][Full Text] [Related]
11. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
Levesque MC; St Clair EW
J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
[TBL] [Abstract][Full Text] [Related]
12. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
13. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
14. Selfie: Autoimmunity, boon or bane.
Ahsan H
J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
[TBL] [Abstract][Full Text] [Related]
15. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
16. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
17. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
18. Aberrant B cell selection and activation in systemic lupus erythematosus.
Kil LP; Hendriks RW
Int Rev Immunol; 2013 Aug; 32(4):445-70. PubMed ID: 23768157
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.
Moulton VR; Suarez-Fueyo A; Meidan E; Li H; Mizui M; Tsokos GC
Trends Mol Med; 2017 Jul; 23(7):615-635. PubMed ID: 28623084
[TBL] [Abstract][Full Text] [Related]
20. B cells as a therapeutic target in autoimmune diseases.
Park YW; Pryshchep S; Seyler TM; Goronzy JJ; Weyand CM
Expert Opin Ther Targets; 2005 Jun; 9(3):431-45. PubMed ID: 15948665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
